Boeing Company (The) (BA) › Analysis

Boeing Company (The) (BA) stock analysis, February 24, 2026: Boeing bounces 2% to $233.50, but can it clear $241-242 resistance?

Published February 24, 2026 · BA chart, levels and live analysis

Key Updates

Boeing shares recovered 2.00% to $233.50 since the February 23 report, demonstrating resilience after the recent 5-day decline of 4.32%. The stock has now retraced approximately half of the pullback from the $241.52 level reached on February 12, maintaining positive YTD momentum at 7.54%. This recovery occurs without new fundamental catalysts, suggesting technical buying interest near the $228-230 support zone. The investment thesis remains intact, supported by operational improvements including 40% fewer supplier-related defect hours and plans to increase 737 production to a record 63 jets per month. The recent consolidation appears to be a healthy pause within the broader recovery trajectory rather than a reversal of the positive operational momentum established in Q4 2025.

Current Trend

Boeing trades at $233.50, up 7.54% YTD but down 7.40% over the past month, reflecting near-term volatility within a broader recovery pattern. The stock has established a trading range between $228-242 over the past two weeks, with the recent 2.00% gain representing a bounce from the lower end of this consolidation zone. The 6-month performance of 1.47% masks significant intra-period volatility, as the stock recovered from production challenges and regulatory constraints imposed in early 2024. The current price remains approximately 5% below Morningstar's $246 fair value estimate, suggesting modest upside to fundamental valuation. Technical support has formed around the $228-230 level, tested twice in recent sessions, while resistance persists near $241-242. The YTD gain of 7.54% outpaces the broader aerospace sector, reflecting investor confidence in Boeing's operational turnaround under CEO Kelly Ortberg's leadership.

Investment Thesis

The investment thesis centers on Boeing's operational recovery and production scaling following years of crisis that began with the 737 MAX crashes in 2019. The company delivered 600 commercial aircraft in 2025, the highest annual total since 2018, and achieved its first annual profit in seven years driven by a $9.6 billion gain from selling its Digital Aviation Solutions business. Boeing's record $682 billion backlog, including over 6,100 commercial airplanes, provides multi-year revenue visibility as production rates increase. The completion of the Spirit AeroSystems acquisition in December 2025 enables direct control over critical supply chain quality, with defects already down 60% since enhanced inspections began. Plans to increase 737 production to a record 63 jets per month represent approximately 15% growth over 18 months, critical for cash flow generation and debt reduction from the current $54.1 billion level. Morningstar projects Boeing will achieve $3 billion in free cash flow in 2026, potentially reaching $10 billion by 2028, contingent on successful 777X certification scheduled for late 2026. The thesis assumes continued regulatory approval for production rate increases, stable supply chain performance, and successful execution of the 737 and 787 production ramps without quality incidents.

Thesis Status

The investment thesis remains on track with no material changes since the February 23 report. Operational execution continues to validate the recovery narrative, with 40% fewer hours spent fixing supplier-related problems and 60% fewer defects from Spirit AeroSystems. The 2.00% price recovery demonstrates investor confidence in the operational improvements despite the absence of new fundamental catalysts. Boeing's competitive position strengthened in January 2026 with 46 deliveries and 103 net orders, significantly outpacing Airbus's 19 deliveries and 49 orders. The company's ability to maintain production momentum while improving quality metrics validates management's focus on stability before aggressive growth. However, concerns raised in Forbes analysis about Boeing's narrow-body strategy highlight longer-term competitive risks that could challenge the thesis beyond 2028. The near-term consolidation between $228-242 reflects appropriate price discovery as investors balance strong operational momentum against elevated debt levels and execution risks inherent in production scaling.

Key Drivers

Production scaling remains the primary value driver, with Boeing planning to increase 737 output to a record 63 jets per month, representing 15% growth over 18 months. The company has installed tooling for a new final assembly line with production startup targeted for mid-year. Supply chain quality improvements provide critical support for production increases, with defects from Spirit AeroSystems down 60% since Boeing enhanced quality control and overall supplier-related problem-solving time reduced by 40%. The Spirit AeroSystems acquisition completed in December 2025 enables direct oversight of fuselage production for the 737 program. Order momentum continues with 103 net new orders in January 2026, more than double Airbus's 49 orders, including major commitments from Aviation Capital Group, Air India, and Delta Air Lines. Cash flow generation represents a critical milestone, with Morningstar projecting $3 billion in free cash flow for 2026, essential for reducing the $54.1 billion debt burden. Regulatory approval remains a key variable, with the FAA having loosened production restrictions to allow 42 jets per month for the 737 MAX, though further increases require continued quality performance. The 777X certification scheduled for late 2026 represents a significant program milestone that could unlock additional cash flow by 2028.

Technical Analysis

Boeing established a consolidation range between $228-242 over the past two weeks, with the current $233.50 price representing a recovery from support tested on February 23 at $228.91. The 2.00% gain since the last report reflects technical buying interest at the lower end of this range, though volume and momentum indicators are not provided in the data. The stock faces near-term resistance at $241-242, last tested on February 12, while support has formed around $228-230. The 5-day decline of 4.32% and 1-month decline of 7.40% contrast with the 7.54% YTD gain, indicating increased volatility as the stock digests the strong Q4 2025 results. The current price trades approximately 5% below Morningstar's $246 fair value estimate, suggesting modest upside to fundamental valuation. The 6-month performance of 1.47% reflects the stock's recovery from regulatory production caps imposed following the January 2024 door plug incident. A sustained break above $242 would likely target the $246 fair value level, while a breach of $228 support could retest the $220-225 zone. The recent price action suggests healthy consolidation within an intact recovery trend rather than a reversal pattern.

Bull Case

Bear Case

Get a message when the BA picture changes — the agent team watches the levels and the news for you.Create a free account

More BA analyses